Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-10-12

FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

The FDA approved a supplemental application for Baraclude (entecavir) submitted by E.R. Squibb & Sons, L.L.C., to modify labeling following the supplemental sub…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baraclude (entecavir)

Snippet

SUPPL AP for BARACLUDE (ENTECAVIR)